PubRank

Mats Johnson

Author PubWeight™ 16.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Computerized training of working memory in children with ADHD--a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2005 5.58
2 [Children and young people with neurodevelopmental problems: Support and efforts must be given even if not all diagnostic criteria are met]. Lakartidningen 2013 1.95
3 European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2013 1.23
4 A comparison of North American versus non-North American ADHD study populations. Eur Child Adolesc Psychiatry 2006 1.03
5 A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs 2013 0.93
6 A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur Child Adolesc Psychiatry 2004 0.90
7 Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs 2013 0.86
8 Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder. CNS Drugs 2012 0.83
9 Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2006 0.77
10 Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder. CNS Drugs 2014 0.77
11 Parental attitudes and experiences of dental care in children and adolescents with ADHD--a questionnaire study. Swed Dent J 2014 0.76
12 [Reply: We find it difficult making our voices heard]. Lakartidningen 2013 0.75
13 [In with updated medical knowledge when ADHD is managed]. Lakartidningen 2015 0.75
14 Lakartidningen 2017 0.75